01 Aug Combining dasatinib with Tamoxifen, may overcome Tamoxifen resistance in breast cancer
Posted at 20:45h
in Breast Cancer
August 1 20100 PHILADELPHIA—Taking a leukemia chemotherapy drug may help breast cancer patients who don't respond to tamoxifen overcome resistance to the widely-used drug, new research from the Kimmel Cancer Center at Jefferson suggests. Interestingly, researchers found that taxoxifen combined with dasatinib, a protein-tyrosine kinase inhibitor, reverses the chemo-resistance caused by cancer-associated...